CN118845882A - 白芷清热解毒止痛关节积液散 - Google Patents
白芷清热解毒止痛关节积液散 Download PDFInfo
- Publication number
- CN118845882A CN118845882A CN202310395333.8A CN202310395333A CN118845882A CN 118845882 A CN118845882 A CN 118845882A CN 202310395333 A CN202310395333 A CN 202310395333A CN 118845882 A CN118845882 A CN 118845882A
- Authority
- CN
- China
- Prior art keywords
- dampness
- effusion
- cold
- yellow wine
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010023215 Joint effusion Diseases 0.000 title claims abstract description 53
- 239000000843 powder Substances 0.000 title claims abstract description 50
- 208000002193 Pain Diseases 0.000 title claims abstract description 35
- 239000003814 drug Substances 0.000 claims abstract description 61
- 230000036407 pain Effects 0.000 claims abstract description 33
- 210000000629 knee joint Anatomy 0.000 claims abstract description 31
- 235000014101 wine Nutrition 0.000 claims abstract description 21
- 230000000694 effects Effects 0.000 claims abstract description 20
- 208000025747 Rheumatic disease Diseases 0.000 claims abstract description 18
- 230000000552 rheumatic effect Effects 0.000 claims abstract description 18
- 241000213006 Angelica dahurica Species 0.000 claims abstract description 17
- 238000000227 grinding Methods 0.000 claims abstract description 6
- 238000002360 preparation method Methods 0.000 claims abstract 5
- 241000411851 herbal medicine Species 0.000 claims description 19
- 235000019441 ethanol Nutrition 0.000 claims description 11
- 239000002775 capsule Substances 0.000 claims description 10
- 201000004595 synovitis Diseases 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 9
- 235000007164 Oryza sativa Nutrition 0.000 claims description 7
- 235000009566 rice Nutrition 0.000 claims description 7
- 235000014347 soups Nutrition 0.000 claims description 7
- 241000132012 Atractylodes Species 0.000 claims description 6
- 235000020066 kaoliang wine Nutrition 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 235000012054 meals Nutrition 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 230000035622 drinking Effects 0.000 claims description 4
- 230000003203 everyday effect Effects 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 206010020751 Hypersensitivity Diseases 0.000 claims description 3
- 230000007815 allergy Effects 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 3
- 240000007594 Oryza sativa Species 0.000 claims 2
- 208000026935 allergic disease Diseases 0.000 claims 2
- 235000021152 breakfast Nutrition 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 229940100691 oral capsule Drugs 0.000 claims 2
- 239000000654 additive Substances 0.000 claims 1
- 238000005303 weighing Methods 0.000 claims 1
- 230000008961 swelling Effects 0.000 abstract description 26
- 206010061218 Inflammation Diseases 0.000 abstract description 25
- 230000004054 inflammatory process Effects 0.000 abstract description 23
- 229940079593 drug Drugs 0.000 abstract description 21
- 230000017531 blood circulation Effects 0.000 abstract description 20
- 239000008280 blood Substances 0.000 abstract description 18
- 210000004369 blood Anatomy 0.000 abstract description 18
- 241001369613 Stephania tetrandra Species 0.000 abstract description 15
- 208000006820 Arthralgia Diseases 0.000 abstract description 12
- 241000092665 Atractylodes macrocephala Species 0.000 abstract description 12
- 241000700605 Viruses Species 0.000 abstract description 12
- 241000894006 Bacteria Species 0.000 abstract description 11
- 206010030113 Oedema Diseases 0.000 abstract description 10
- 239000000203 mixture Substances 0.000 abstract description 9
- 239000003053 toxin Substances 0.000 abstract description 9
- 231100000765 toxin Toxicity 0.000 abstract description 9
- 108700012359 toxins Proteins 0.000 abstract description 9
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 8
- 230000001225 therapeutic effect Effects 0.000 abstract description 7
- 238000000034 method Methods 0.000 abstract description 6
- 230000002265 prevention Effects 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 229940126534 drug product Drugs 0.000 abstract 1
- 230000037257 muscle growth Effects 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 210000000605 viral structure Anatomy 0.000 abstract 1
- 235000019991 rice wine Nutrition 0.000 description 29
- 206010063045 Effusion Diseases 0.000 description 28
- 206010042674 Swelling Diseases 0.000 description 26
- 208000004880 Polyuria Diseases 0.000 description 13
- 230000035619 diuresis Effects 0.000 description 13
- 230000003110 anti-inflammatory effect Effects 0.000 description 10
- 208000010668 atopic eczema Diseases 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000000172 allergic effect Effects 0.000 description 7
- 230000000202 analgesic effect Effects 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 230000003213 activating effect Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 241000209094 Oryza Species 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 235000019640 taste Nutrition 0.000 description 5
- 241000125175 Angelica Species 0.000 description 4
- 235000001287 Guettarda speciosa Nutrition 0.000 description 4
- 206010023232 Joint swelling Diseases 0.000 description 4
- 230000001760 anti-analgesic effect Effects 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000002757 inflammatory effect Effects 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 210000003127 knee Anatomy 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 230000001754 anti-pyretic effect Effects 0.000 description 3
- 239000002221 antipyretic Substances 0.000 description 3
- 206010003246 arthritis Diseases 0.000 description 3
- 229940126678 chinese medicines Drugs 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000002458 infectious effect Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000001503 joint Anatomy 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- 230000000472 traumatic effect Effects 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 201000005569 Gout Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 206010028735 Nasal congestion Diseases 0.000 description 2
- 208000037656 Respiratory Sounds Diseases 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 206010047924 Wheezing Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 210000001188 articular cartilage Anatomy 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000003181 biological factor Substances 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 229940088592 immunologic factor Drugs 0.000 description 2
- 239000000367 immunologic factor Substances 0.000 description 2
- 210000000281 joint capsule Anatomy 0.000 description 2
- 208000018937 joint inflammation Diseases 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 201000008482 osteoarthritis Diseases 0.000 description 2
- 208000008423 pleurisy Diseases 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 206010039083 rhinitis Diseases 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 239000007939 sustained release tablet Substances 0.000 description 2
- 210000001179 synovial fluid Anatomy 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- 206010002199 Anaphylactic shock Diseases 0.000 description 1
- 241000382455 Angelica sinensis Species 0.000 description 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 231100000699 Bacterial toxin Toxicity 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010065390 Inflammatory pain Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010072970 Meniscus injury Diseases 0.000 description 1
- DUGOZIWVEXMGBE-UHFFFAOYSA-N Methylphenidate Chemical compound C=1C=CC=CC=1C(C(=O)OC)C1CCCCN1 DUGOZIWVEXMGBE-UHFFFAOYSA-N 0.000 description 1
- 208000016285 Movement disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 208000012876 acute enteritis Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000002686 anti-diuretic effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 239000000688 bacterial toxin Substances 0.000 description 1
- 238000013124 brewing process Methods 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- RZEKVGVHFLEQIL-UHFFFAOYSA-N celecoxib Chemical compound C1=CC(C)=CC=C1C1=CC(C(F)(F)F)=NN1C1=CC=C(S(N)(=O)=O)C=C1 RZEKVGVHFLEQIL-UHFFFAOYSA-N 0.000 description 1
- 229960000590 celecoxib Drugs 0.000 description 1
- 208000036319 cervical spondylosis Diseases 0.000 description 1
- 230000009693 chronic damage Effects 0.000 description 1
- 208000024035 chronic otitis media Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 208000027744 congestion Diseases 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229960001193 diclofenac sodium Drugs 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 208000014987 limb edema Diseases 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 229960001344 methylphenidate Drugs 0.000 description 1
- 230000004220 muscle function Effects 0.000 description 1
- 230000036640 muscle relaxation Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- JGMJQSFLQWGYMQ-UHFFFAOYSA-M sodium;2,6-dichloro-n-phenylaniline;acetate Chemical compound [Na+].CC([O-])=O.ClC1=CC=CC(Cl)=C1NC1=CC=CC=C1 JGMJQSFLQWGYMQ-UHFFFAOYSA-M 0.000 description 1
- 208000005801 spondylosis Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 229940037128 systemic glucocorticoids Drugs 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 201000005060 thrombophlebitis Diseases 0.000 description 1
- 229940126702 topical medication Drugs 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明中药粉热黄酒调膏外用热敷剂制备技术领域,稳定安全治风湿膝关节积液中药热黄酒组合物调膏外用热敷制备方法,由以下重量克数中药热黄酒制成将白芷200g白术200g防己200g三味研细粉180‑200目温热黄酒40‑60g四药调成膏热敷患处即该药产品,按古典传承结合现代中药粉热黄酒调膏热敷制剂工艺四味药混合获得中药热黄酒制备效果显著调膏热敷剂。特点白芷白术清热解毒止痛祛关节积液抗菌除寒湿邪热风寒澡湿水肿炎症,敛寒湿水肿吸收积液活血化瘀解毒除寒瘀细菌病毒组分,防己祛风湿止痛消肿散寒湿邪热清燥去火,生肌散风湿痹痛祛寒湿膝关节积液病毒,对关节积液病毒细菌寒湿澡热功毒消炎利湿祛浓肿增强预防关节积液形成治愈显著疗效。
Description
技术领域:
1、本发明涉及一种治疗风湿性膝关节滑膜炎积液病外用中草药黄酒调制热敷剂。
背景技术:
1、膝关节炎由关节囊滑膜层和关节软骨组成封闭腔隙,关节囊滑液称为膝关节腔积液。膝关节风湿性滑膜炎退行性病变骨质增生半月板损伤等症,表现为关节红肿疼痛充血肿胀走路一拐一瘸功能障碍关节畸形病变严重者导至关节残疾等膝盖关节积液常见病,严重影响患者正常生活工作需根据诱因积极预防减少发病几率。关节积水临床中病因较多如骨性关节炎骨值增生、关节滑膜炎风湿痛风感染性疾病外伤等,正常人体关节均有一定液体关节腔滑液起润滑营养和保护关节作用属人体正常生理代谢所必需物质,但关节积液明显增加超出正常水平或性质发生改变如透明黏稠液体变浑浊厚重液体属异常。骨性关节炎是中老年与长期运动患者骨质软骨造成磨损局部产生无菌性炎症、软骨面磨损后大量渗液积液可造成关节腔积水滑膜炎细菌病毒感染或结核感染等造成感染性滑膜炎肿痛,关节腔内大量液体渗出并伴细菌病毒,而液体比较浑浊颜色呈草绿色及黄色等,根据细菌性质数量颜色有所不同区分风湿或外伤所致疾病局部关节腔积液。如尿酸增高痛风病患者可形成尿酸结石,创伤后局部大量出血水肿等造成关节腔积液需根据导致积液原因针对性治疗,过度磨损身体刺激滑膜炎免疫系统疾病等都会导致膝关节腔出现积液,病患宜多休息避免不当运动不做剧烈活动补充高蛋白质维生素C等营养物质。关节积液可由物理性因素化学性因素、生物性因素免疫性因素等引起,物理因素损伤如撞伤摔伤导致局部骨折势必引发关节积液,慢性损伤导致滑膜炎或关节软骨面损伤引发关节积液,化学性因素由膝关节内注射药物引发关节积液,生物性因素主要指受结核病菌或细菌感染引发关节积液。免疫性因素指类风湿或强直性脊柱炎等疾病引发关节积液这几种病情发生可导致膝关节腔积液问题、给身体带来伤害引发膝关节腔积液变奇形至残等。短期服用解热镇痛药双氯芬酸钠缓释片、庆大莓素布洛芬缓释片、甲沷尼龙塞来昔非甾啊莫西林糖皮质激素等口服可减轻关节疼痛肿胀减少炎症积液,缓解关节积液引起炎症疼痛,可关节腔内注射快速消炎止痛及手术治疗关节穿刺抽液、适用关节积液量较大患者有效减轻关节肿痛炎症。中药以抗菌清热消肿止痛解毒吸收敛湿袪膝盖关节积液消炎除浓血水止痛、袪湿化瘀活血通经温络敛湿拔毒除浓肿镇痛杀灭关节细菌病毒热寒湿气等治疗法为佳。
2、关节积液常见外伤性或炎症性关节积液,如外伤性关节积液只需治疗原发外伤疾病关节积液可自行缓慢吸收,炎症性关节积液需消炎止痛,抗生素感染性炎症需使用抗生素或通过关节穿刺关节镜穿入有创治疗关节积液排出治愈,经多年自主研究发明白芷清热解毒止痛关节积液散,专治风湿膝关节腔积液病消肿止痛炎症除浓肿病毒血水积液邪热湿气解热镇痛特效良药妙方,能迅速抗菌消炎解毒清热止痛、活血化凝通经活络敛湿消肿拔毒灭菌,除肿胀血水积液病毒素解毒散寒湿热邪消炎利水吸收积液起立竿见影特殊疗效,不需要手术吃药打针快速消炎清热止痛解毒杀菌、袪浓血水积液肿胀吸收膝关节积液浓肿湿气热邪功毒利水平衡膝关节内积液病毒分解质,除寒敛湿清热消炎止痛解除病毒素袪浓肿积水起到良好治愈作用效果。
3、使用该药病友用药后须每天连续使用一疗程17天才可达理想治疗效果,每包药粉600克可用一疗程患部大小视情况适量增减药粉量调拌均匀热敷为宜。多年临床试验娄用娄效免费医治送药急救不少人治癒率97%以上。轻者用药17天见效连用40天治癒,重患者40-60天治癒17天为一疗程每包药粉量600克可用一疗程。换上药后患处用医用一次性沙布块抱扎固定防掉漏药不沾水保暖适当休息、不做激列运动活动配合中医理疗穴位放血间隔针炙疗效更佳,膝关节积液病患坚持用药17天见效40天根治多年无复发。患膝关节积液病友需早就医日久难愈不利康复,仅需病患每天双膝或单膝关节患处各换药一次,轻患持续用药40天痊癒,重者40-60天治癒少数病患需视个人病况轻重酌情增减一疗程药为宜以稳固病情复发,如少数病患外敷药后出现皮肤騒痒红肿过敏应停药改为口服胶襄,每天按时换一次药即可不需要打针吃药,是保守治愈风湿膝关节积液炎症吸水敛寒湿邪热解毒消水肿病菌毒素积液止痛消炎利水根治疗效最佳方法。
发明内容:
1、为此本发明提供一种治疗风湿性膝关节积液病的中草药粉热黄酒组合物外用调膏剂热敷配方,其特征由以下重量份中药研磨细粉热黄酒配调制成:生白芷200g、白术200g、防己200g三味精选研磨细粉180-200目、黄酒40-60g加温热共四味调成膏状外用热敷于患处局部每天换药1次或把白芷100g、白术100g、防己100g三味研成细粉未190-210目用0.5g胶襄包装成粒、成人每次用温热黄酒或高梁酒送服10-12克,小童减半服0.3-0.6克每天早中晚饭后三次、如不能喝酒或喝酒过敏者用米汤温热送服。
2、进一步所述治疗风湿性膝关节积液病中药粉热黄酒组合物外用调膏热敷配方,其特征由以下重量份中草药研磨细粉热黄酒调制成:白芷200g、白术200g、防己200g三味研磨细粉180-200目、黄酒40-60g加温热共四味调成膏状外用热敷于患处局部每天换药1次或把白芷100g、白术100g、防己100g三味研成细粉未190-210目用0.5g胶襄包装成粒、成人每次用黄酒或高梁酒加热微温送服10-12克,小童减半服0.3-0.6克每天早中晚饭后三次如不能喝酒或喝酒过敏者用温热米汤送服。
3、进一步所术冶疗风湿膝关节积液病中草药粉热黄酒组合物外用调膏剂热敷配方,其特征在由以下重量份中草药研磨细粉热黄酒制成:将生白芷200g、白术200g、防己200g三味研磨细粉180-200目、黄酒40-60g加温热共四味调成膏状外用热敷于患处局部每天换药1次或把白芷100g、白术100g、防己100g三味研成细粉190-210目用0.5g胶襄包装成粒、成人每次用温热黄酒或高梁酒送服10-12克,小童减半服0.3-0.6克每天早中晚饭后三次如不能喝酒或喝酒过敏者用米汤温热送服。
4、另一方面该发明中草药粉热黄酒调制膏状外用热敷患部中药物、属专治风湿性膝关节积液病变炎症疼痛良药妙方,对膝关节积液起到抗菌清热消肿止痛解毒、活血通经活络袪湿除寒湿邪热消炎止痛吸收关节内病毒素积液敛寒湿热邪功毒利水、消肿吸收积液拔浓杀灭真菌细菌等感染病毒依原体特殊治疗关节积液病最佳治疗方法。
5、要求1项所述中草药粉热黄酒外用调膏状组合物。
6、进一步所述药物为中草药粉、热黄酒调膏外用热敷剂。
中草药粉热黄酒调制膏状外用热敷剂:
1、步骤将生白芷200g、白术200g、防己200g三味精选混合均匀研磨成细粉180-200目、黄酒40-60g加温热共四味外用调膏剂热敷于患处局部每天换药一次或把白芷100g、白术100g、防己100g三味研成细粉190-210目用0.5g胶襄包装成粒、成人每次用温热黄酒或高梁酒送服10-12克,小童减半服0.3-0.6克每天早中晚三次,如不能喝酒或喝酒过敏者用米汤温热送服。
有益效果:
1、白芷属伞形科当归植物药用根发散风寒要药,杭白芷质量最佳性味归经肺胃大肠经,芳香开窍解表散寒祛风止痛燥湿止带,清湿寒邪热止痒消肿清利止痛排脓风寒感冒头疼风湿痹痛各种鼻炎鼻塞不通鼻涕不止前额疼痛的鼻炎特效。具燥湿解表除寒其味辛性温芳香祛湿解热镇痛除风消肿排浓生肌活血止痛等功效,风寒导致头痛鼻塞能袪寒除湿消炎止痛,本方促进血液流通缓解膝关节炎症镇痛利水湿和中、散寒风湿受寒湿邪阻导致膝关节积液病症清热解毒消炎止痛袪寒湿热利水活血生肌等功效作用。
2、白术一种常见中草药属菊科类多年生草本植物药用价值高性温味甘苦,根茎入药白术燥而不烈功补兼施良药,药理研究证明具广泛药用活性抗肿瘤修复胃黏膜抗炎镇痛、保肝降糖调节脂代谢利尿改善记忆力抗血小板衰老氧化治疗肾炎子宫平滑肌、慢性中耳炎白色康诊调整水液代谢等抗菌止汗镇静安胎健脾胃提高免疫脾脏补气要药十方九术,补气腱脾燥湿利水主治脾气虚弱痰饮水肿、表虚自汗水肿黄胆呕泻湿利脾虚少食、眩晕袪风寒目眩头痛水肿胀满风眼火目消化不良、脾虚胎动不安慢性腰痛对治疗肝硬化腹水原发性肝癌急性肠炎及白细胞减少症特殊疗效,本方作用抗菌散风除湿消炎止痛清利水湿解毒散寒固表、促进平滑肌功能吸收积液炎症袪浓肿水湿寒气特效作用。
3、防己为科植物粉防己干燥根属风湿类要药治疗风湿痹痛消炎止痛热痹导致骨节烦痛屈伸不利等症,味辛苦性寒归膀胱肺经祛风湿止痛利水消肿除寒湿邪热清燥去火,辛能散风湿痹痛利水消肿清热袪风除湿燥湿,苦寒降泄祛风除湿又能清热解毒消炎止痛,降利清热利水道善下焦膀胱湿热下肢水肿,小便不利消水肿治胸膜炎祛风除湿止燥敛积水寒湿病毒能清热除湿祛风止痛利水消肿湿疹疮毒,高血压病水肿脉浮身重呼吸迫促或喘息如心力衰竭引起水肿和喘息,风邪外袭水湿内阻头面身肿小便不利风湿证此药具镇痛解热抗炎解毒抗过敏性休克、利尿降压肌肉松弛抗阿米巴原虫等治疗作用。现代临床风湿性关节炎类风湿关节炎肩周炎颈椎病过敏性皮炎湿疹血栓性静脉炎、高血压慢性肝纤维化支气管哮喘病等,本方对膝关节积液抗菌消炎清热解毒除寒湿热邪病毒素止痛功毒祛风止痛消肿功效。
4、热黄酒具舒筋活血促进食欲养血、补血养颜等黄酒性热味甘辛具通血脉活血化瘀散湿气除风下气功效,含锌是能量代谢和蛋白合成重要成分并含多种醇类甘油糖分有机酸氨基酸维生素,热黄酒活血祛寒消食化积温经活血通络养血驱寒祛湿促进血液循环新陈代谢,黄酒酿造过程保持原有营养成分其糖化胶质有利人体健康。治疗方面喝调用法不同其疗效也有差异如凉饮黄酒消化不良、厌食可促消食化积镇静心跳过速烦躁等显著作用,本方加热黄酒对风湿膝关节积液具祛风除湿消炎温经活血通络养血驱寒祛湿止痛散湿活血除寒舒筋通经活络、活血化瘀腰背痛手足麻木震颤对风湿风寒湿热膝关节肿痛积液炎症细菌病变调中活血化瘀驱寒袪湿消炎止痛显著疗效作用。
5、本发明白芷清热解毒止痛关节积液散,对治疗膝盖风湿关节积液病达理想疗效,多年来长期免费急救给亲友街访邻里送药治愈几百人有效率达97%以上,其特点综合调节作用增强方中选用白芷、白术对类风湿关节积液病具抗菌消炎袪湿散热解毒、活血化瘀吸收积液寒湿邪热止痛敛湿散寒消肿利水平衡积液寒湿邪热病毒素兼标本同治良效。防己治风湿痹痛骨关节烦痛屈伸不利水肿积水胸膜炎祛风除湿止燥驱寒、清热除湿抗菌消炎止痛解毒祛风除湿利水消肿清热功效。祛风湿止痛利水消肿除寒湿邪热清燥去火,生肌散风湿痹痛消炎袪浓肿三味中药热黄酒巧妙配伍故能袪除风湿膝关节吸收积液病变原微生物,对关节积液病毒细菌寒湿燥热功毒消炎利水湿除浓肿血水积液具较强抑制作用黄酒加温热舒筋活血通血脉化瘀行气驱寒散湿,温经通络除风活血化瘀关节肿痛散寒消炎解毒调和药性散寒驱寒除湿消炎止痛组分,促使治疗关节积液病毒素分解细菌炎症病毒依原体,袪湿化邪开郁燥湿热拔毒温经活血消炎化浓肿调和炎症积液吸收治愈风湿关节积液要点起特殊神奇治愈疗效。
具体实施方式:
配方:生白芷200g、白术200g、防己200g三味精选混合均匀研磨成细粉180-200目、黄酒40-60g加温热共四味外用调膏状热敷于患处局部每天换药一次或把白芷100g、白术100g、防己100g三味研成细粉未190-210目用0.5g胶襄包装成粒、成人每次用温热黄酒或高梁酒送服10-12克,小童减半服0.3-0.6克每天早中晚饭后三次,如不能喝酒或喝酒过敏者用米汤温热送服。
加工方法:
1、将配方中以上三味中药精选,按准确分量克数称好混合一块将混合组分粉碎均匀研磨成细粉180-210目、黄酒40-60g加温热共四味外用调制成膏状热敷于患处局部每天换药一次或把白芷100g、白术100g、防己100g三味研成细粉190-210目用0.5g胶襄包装成粒、用消毒凉干瓶装备用或用60-70号塑料封口包装袋包装好即是该产品。
2、根据权利要求书1所述外用热敷调膏剂治疗风湿膝关节滑膜炎积液病的中草药热黄酒物,属外用中药粉热黄酒所述药物为中草药粉热黄酒调制成膏状外用热敷剂。
下面介绍本药治疗风湿膝关节滑膜炎积液病的临床观察试验:
1、病例选择:1997以来选择143例进行临床观察试验,均以高等医药院校教材(中医骨科内外结合科学)(一三四版)诊断标准为依据。
治疗方法:
1、使用本药外用病患成人小童1日换药一次、轻患用药17天一疗程见效连用40天治癒,重患者40-60天治癒一疗程17天每包药粉量600克可用一疗程,注意用药量少会影响疗效如患面比较大或小可适当增减用药量调热敷为宜。
2、使用该药病友用药后须每天连续使用一疗程17天才可达理想治疗效果,每包药粉600克可用17天一疗程。
3、观察变化配合治疗前后期间、没有明显不良副作用等反应。
4、不用其它药物。
疗效观察:
1、疗效标准、显效——无他不适。风湿膝关节积液病经治疗恢复达正常水平。
2、疗效观察、疗效标准显效——无他不适。
3、有效——临床症状减轻好转、最终根治。
4、无效——临床症状风湿膝关节积液得到改善、病症减轻。
观察结果:
病名 | 疗效 | 病列数 | 比率 | 总有效率(%) |
风湿膝关节积液病 | 显效 | 107 | 76.0 | |
有效 | 27 | 21.0 | 79% | |
无效 | 4 | 3.1 |
小结:
1、从本次134例为期1-17个月不等临床观察,本药对风湿膝关节积液病患者治疗总有效率为97%。
2、经临床使用前后至今未发现明显不良反应,说明该药外用热敷时并无明显毒副作用。
3、使用无风险省时简单方便易用,宜于应用推广。
注意事项:
一、本白芷清热解毒止痛关节积液散,病患每天换药1次再膝关节左、右患部调制膏状外用热敷用医用一次性沙布块包扎即可,沙布块应保持干澡不沾水保暖休息(该药酒调膏剂属外用药,切忌不入眼请不要给小童拿玩或误食)如误食量多请喝一杯500克红糖水即可。
二、使用该药病友用药后,须每天连续使用一疗程为17天才可达理想治疗效果,每包药粉600克可用一疗程。注意用药量少会影响疗效、如患面比较大或小可适当增减用药量调敷为宜。
三、本药品保质期一年有效。膝关节积液轻患用药17天一疗程见效连用40天治癒,重患40-60天治癒,一疗程17天每包药粉量600克可用一个疗程,注意用药量少会影响疗效如患面比较大或小可适当增减用药量调敷为宜。重患病友用药60天视自身病情复杂轻重可适当酌情增减一疗程巩固治疗不易复发。
用法用量:小童用药量减半、成人小童病患用该白芷清热解毒止痛关节积液散每天换一次药即可,广大病友请尊医嘱说明使用为妥。
不良反应:无毒副作用少数患者有轻微过敏。
药品性状:纯中草药挑选混合,精制研磨细粉180-210目热黄酒配调制而成。顔色褐黄色或淡黄色粉未状。气微淡、味微苦。
规格:每袋装药粉600克,可用17天即是一疗程用药量。
外用包装:外用中药粉无毒副作用,瓶装备用或60-70号白色或黄色塑料封口袋子封装。
【宜忌】如皮肤发红起红点騒痒过敏者禁用。
保存期:保质期一年有效。
Claims (2)
1.白芷清热解毒止痛关节积液散其特征在于治疗风湿性膝关节滑膜炎积液病,配方将生白芷200g、白术200g、防己200g三味君药配以辅药黄酒40-60g加温热共四味外用调膏剂热敷于患处局部每天换药一次或把白芷100g、白术100g、防己100g三味研成细粉未190-210目、用0.5g胶襄包装成粒成人每次用温热黄酒或高梁酒送服10-12克,小童减半服0.3-0.6克每天早中晚饭后三次服用,如不能喝酒或喝酒过敏者用米汤送服。主要对风湿性膝关节积液具显著治癒效果。加工方法将配方中以上三味中草药精选,按准确分量克数称好混合一块、黄酒40-60g加温热共四味外用调膏热敷于患处局部每天换药一次或把白芷100g、白术100g、防己100g三味研成细粉未190-210目用0.5g胶襄包装成粒、成人每次用温热黄酒或高梁酒送服10-12克,小童减半服0.3-0.6克每天早中晚饭后三次服用,如不能喝酒或喝酒过敏者用温热米汤送服、也即是该药产品。
2.根据权利要求书配方1项所述治疗风湿膝关节滑膜炎积液病的中草药热黄酒调膏状药物、属外用中草药热黄酒所述药物为外用调膏热敷剂及胶襄包装粒口服中草药粉粒口服胶襄剂药,不含添加剂及化学物纯中草药温热黄酒配方调制外用热敷剂与口服胶襄药粒。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310395333.8A CN118845882A (zh) | 2023-04-13 | 2023-04-13 | 白芷清热解毒止痛关节积液散 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310395333.8A CN118845882A (zh) | 2023-04-13 | 2023-04-13 | 白芷清热解毒止痛关节积液散 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN118845882A true CN118845882A (zh) | 2024-10-29 |
Family
ID=93161512
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310395333.8A Pending CN118845882A (zh) | 2023-04-13 | 2023-04-13 | 白芷清热解毒止痛关节积液散 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN118845882A (zh) |
-
2023
- 2023-04-13 CN CN202310395333.8A patent/CN118845882A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101062194B (zh) | 治疗骨病、骨折的药物及制备方法 | |
CN102626487B (zh) | 一种治疗风寒湿邪的中药丸剂及其制备方法 | |
CN104815318A (zh) | 一种治疗痛风的中药制剂 | |
CN102028901B (zh) | 一种治疗膝关节增生性滑膜炎的中药 | |
CN103784550B (zh) | 用于消肿止痛的中药组合物及其制剂 | |
CN102274372B (zh) | 一种治疗外伤骨折风湿及各种出血的中药 | |
CN105998241A (zh) | 用于肾阳虚痹证的中成药 | |
CN104324097B (zh) | 治疗痛痹型膝关节骨性关节炎的外用中药组合物 | |
CN1315516C (zh) | 一种治疗风湿病的药物 | |
CN118845882A (zh) | 白芷清热解毒止痛关节积液散 | |
CN106620471A (zh) | 一种用于骨伤术后康复的中药组合物 | |
CN105561270A (zh) | 一种外敷止痛中草药及其制备方法 | |
CN106421255B (zh) | 一种外用中草药组合物及其应用 | |
CN111329921A (zh) | 治疗筋骨疼痛的中药组合物及其药物、制备方法与应用 | |
CN109806351A (zh) | 颈肩腰腿痛温敷散 | |
CN109289020A (zh) | 中医穴位磁热定向透药 | |
CN102078588B (zh) | 一种治疗骨质增生的中药联合制剂及其制备方法 | |
CN103285116B (zh) | 一种用于治疗幼儿感冒的中药制剂 | |
CN103340931B (zh) | 一种治疗腰椎病的喷剂 | |
CN105920229A (zh) | 一种治疗急性踝关节扭伤的中药组合物 | |
CN105362944A (zh) | 一种治疗骨科扭挫伤的中药膏剂 | |
CN119424516A (zh) | 一种用于治疗或预防膝骨关节炎的膝痹方及其制备方法 | |
CN106361979A (zh) | 一种治疗风湿性关节炎的中药 | |
CN105169054A (zh) | 一种治疗急慢性骨关节炎的中药制剂及其制备方法 | |
CN117180389A (zh) | 一种治疗骨伤病的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |